Latest Breaking News On - Biosimilars companies - Page 1 : vimarsana.com

Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Glenmark Pharmaceuticals : receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%

Press Release For Immediate Distribution ...

Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023-24

Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance

Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance - 'Ichnos Glenmark Innovation'

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24

Pti: Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24

Glenmark Pharma reports consolidated revenue growth of 6.3 per cent and adjusted EBITDA growth of 8.3 per cent YoY for Q2 FY 2023-24

Glenmark Pharma receives ANDA approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi in Europe and South Africa